Literature DB >> 18380959

Obesity and gynaecological cancer.

Geoffrey Lane1.   

Abstract

Obesity is now considered to be a global epidemic. The problem of obesity has significant implications for the diagnosis and treatment of gynaecological cancer. The cancer most frequently associated with obesity is that of the endometrium. The risk of endometrial cancer is 2-3 times higher in overweight and obese women. Obesity also adversely affects survival in most studies. With regard to ovarian cancer the evidence is inconsistent. Obesity in young adulthood may be more important than that in later life. With regard to survival obesity has an adverse effect but not in early stage disease. Few data are available regarding cervical cancer and obesity. There is evidence that obesity is associated with adenocarcinoma rather than squamous carcinoma. Data on vulval cancer and obesity are scant.

Entities:  

Mesh:

Year:  2008        PMID: 18380959     DOI: 10.1258/mi.2007.007036

Source DB:  PubMed          Journal:  Menopause Int        ISSN: 1754-0453


  9 in total

1.  TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.

Authors:  De-Ke Jiang; Lei Yao; Wei-Hua Ren; Wen-Zhang Wang; Bo Peng; Long Yu
Journal:  Med Oncol       Date:  2010-06-15       Impact factor: 3.064

2.  Impact of obesity on ovotoxicity induced by 7,12-dimethylbenz[a]anthracene in mice.

Authors:  Jackson Nteeba; Shanthi Ganesan; Aileen F Keating
Journal:  Biol Reprod       Date:  2014-03-27       Impact factor: 4.285

Review 3.  Energy Metabolism in Gynecological Cancers: A Scoping Review.

Authors:  Ana Paula Pagano; Katherine L Ford; Kathryn N Porter Starr; Nicole Kiss; Helen Steed; Janice Y Kung; Rajavel Elango; Carla M Prado
Journal:  Int J Environ Res Public Health       Date:  2022-05-25       Impact factor: 4.614

Review 4.  Obesity and cholangiocarcinoma.

Authors:  Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

5.  The aporphine alkaloid boldine induces adiponectin expression and regulation in 3T3-L1 cells.

Authors:  Bangning Yu; Carla Cook; Nalini Santanam
Journal:  J Med Food       Date:  2009-10       Impact factor: 2.786

6.  Association between MDM2 SNP309 and endometrial cancer risk: A PRISMA-compliant meta-analysis.

Authors:  Xinwei Zou; Yi Zhang; Lin Zhang; Jiaxi Li; Chenjie Zhu; Qiuhong Cheng; Jinhua Zhou; Youguo Chen
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer.

Authors:  Jae Kwan Lee; Kyeong A So; Chandrika J Piyathilake; Mi Kyung Kim
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

8.  MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis.

Authors:  Qiliu Peng; Cuiju Mo; Aiping Qin; Xianjun Lao; Zhiping Chen; Jingzhe Sui; Junrong Wu; Limin Zhai; Shi Yang; Xue Qin; Shan Li
Journal:  J Exp Clin Cancer Res       Date:  2013-11-03

9.  Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation.

Authors:  Travis T Sims; Molly B El Alam; Tatiana V Karpinets; Stephanie Dorta-Estremera; Venkatesh L Hegde; Sita Nookala; Kyoko Yoshida-Court; Xiaogang Wu; Greyson W G Biegert; Andrea Y Delgado Medrano; Travis Solley; Mustapha Ahmed-Kaddar; Bhavana V Chapman; K Jagannadha Sastry; Melissa P Mezzari; Joseph F Petrosino; Lilie L Lin; Lois Ramondetta; Anuja Jhingran; Kathleen M Schmeler; Nadim J Ajami; Jennifer Wargo; Lauren E Colbert; Ann H Klopp
Journal:  Commun Biol       Date:  2021-02-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.